Larvol Delta - Candel-Therapeutics-to-Host-Investor-Conference-Call-Following-Presentation-of-Extended-Data-from-Phase-3-Trial-of-Aglatimagene-Besadenovec-in-Localized-Prostate-Cancer-at-the-American-Urological-Association-2026-Annual-Meeting

ProstAtak (aglatimagene besadenovec) - Candel Therap

https://www.globenewswire.com/news-release/2026/05/04/3286676/0/en/candel-therapeutics-to-host-investor-conference-call-following-presentation-of-extended-data-from-phase-3-trial-of-aglatimagene-besadenovec-in-localized-prostate-cancer-at-the-amer.html

May 4, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next